Targeting Proteasomes with Naturally Occurring Compounds in Cancer Treatment

Author(s): V. Cecarini, M. Cuccioloni, M. Mozzicafreddo, L. Bonfili, M. Angeletti, A. M. Eleuteri

Journal Name: Current Cancer Drug Targets

Volume 11 , Issue 3 , 2011

Become EABM
Become Reviewer

Abstract:

Aberrant cellular proliferation and compromised apoptotic pathways are hallmarks of cancer aggressiveness, and in this framework, the role of protein degradation machineries have been extensively dissected. Among proteases, the proteasome is unequivocally central in the intracellular regulation of both these processes, thus several proteasome-directed therapies have been investigated, aiming at controlling its activity and possibly restoring normal cell functions. Numerous studies reported proteasome inhibitors (both synthetic and natural occurring) to potently and selectively induce apoptosis in many types of cancer cells. In this review, we discuss recent advances in proteasomal modulation by some natural occurring polyphenols, globally providing evidence of the proteasome role as therapeutic target in cancer treatment.

Keywords: Apoptosis, cancer, polyphenols, proteasome

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 11
ISSUE: 3
Year: 2011
Page: [307 - 324]
Pages: 18
DOI: 10.2174/156800911794519815
Price: $65

Article Metrics

PDF: 9